Envoy Medical, Inc. (COCH)
(Delayed Data from NSDQ)
$1.51 USD
+0.03 (2.03%)
Updated Aug 6, 2025 03:57 PM ET
After-Market: $1.49 -0.02 (-1.32%) 6:34 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Envoy Medical, Inc. has a market cap of $31.56M, which represents its share price of $1.48 multiplied by its outstanding shares number of 21.33M. As a small-cap company, COCH's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
COCH 1.51 +0.03(2.03%)
Will COCH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for COCH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COCH
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates
908 Devices Inc. (MASS) Reports Q3 Loss, Lags Revenue Estimates
COCH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Orthofix (OFIX) Q3 Earnings Surpass Estimates
Masimo (MASI) Q3 Earnings and Revenues Top Estimates
Integra LifeSciences (IART) Beats Q3 Earnings and Revenue Estimates
Other News for COCH
Envoy Medical GAAP EPS of -$0.32, revenue of $0.08M
Envoy Medical Reports on Second Quarter 2025 Results | COCH Stock News
Envoy Medical Expands Patent Portfolio with New Issuances in the United States | COCH Stock News
Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia | COCH Stock News
New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, ...